# A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis

> **NCT00540618** · PHASE2 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 420 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** MEDI-507
- **OTHER:** Placebo
- **DRUG:** MEDI-507
- **DRUG:** MEDI-507

## Key facts

- **NCT ID:** NCT00540618
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-09
- **Primary completion:** —
- **Final completion:** 2003-07
- **Target enrollment:** 420 (ACTUAL)
- **Last updated:** 2007-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00540618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00540618, "A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00540618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*